Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Meningeal Carcinomatosis × Folic Acid × Clear all

Phase

Phase 1/2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Recurrence 1 Polycystic Ovary Syndrome 1 Ovarian Neoplasms 1 Meningeal Carcinomatosis 1 Lymphoma, T-Cell, Peripheral 1 Lung Neoplasms 1 Insulin Resistance 1 Infertility 1 Fallopian Tube Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Pemetrexed 7 Radiotherapy 3 Trastuzumab 2 Dexamethasone 2 toripalimab 1 sacituzumab govitecan 1 pertuzumab 1 Vitamin B 12 1 Rituximab 1 Folic Acid 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05289908 2025-05-04

Intrathecal Pemetrexed for Leptomeningeal Metastasis

The First Hospital of Jilin University

Phase 1/2 Completed

Meningeal Carcinomatosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡